Search clinical trials for: dolutegravir (Tivicay®) - Phase 1

Total 1134 results

ANRS, Emerging Infectious Diseases
ViiV Healthcare

Completed

A Trial Evaluating Maintenance Therapy With Lamivudine (Epivir®) and Dolutegravir (Tivicay®) in Human Immunodeficiency Virus 1 (HIV-1) Infected Patients Virologically Suppressed With Triple Highly Active Antiretroviral Therapy (HAART) (ANRS 167 Lamidol)

HIV-1 Infection

France
University of Melbourne
The Alfred; ViiV Healthcare

Completed

Dolutegravir Impact on Residual Replication (DIORR)

HIV

Australia
Medical University of South Carolina

Completed

COAST: Coiling of Aneurysms Smaller Than 5mm With Hypersoft® and Hydrogel Coils (COAST)

Small Intracranial Aneurysms

United States
Janssen Research & Development, LLC

Completed

A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin Lymphoma

Relapsed or Refractory Hodgkin Lymphoma

France, Germany
Duke University
National Institute of Mental Health (NIMH)

Completed

CAMPUS - Feasibility Sub-Study (CAMPUS-Feas)

Suicide

United States
Centre Hospitalier Régional d'Orléans

Terminated

Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients (MONCAY)

HIV

France
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA)

Completed

Nudges and Incentives to Enhance the Opioid Treatment Workforce

Opioid Abuse (Disorder)

United States
Shenzhen Precision Health Food Technology Co. Ltd...

Completed

The Efficacy of White Kidney Bean on Oral Glucose Tolerance Test

Diabetes | Sugar; Blood, High

China
Brigham and Women's Hospital

Withdrawn

Lung Irradiation for COVID-19 Pneumonia

SARS-CoV 2

United States
University of Aberdeen

Recruiting

Focus on Fibre Study

Appetitive Behavior

United Kingdom
University of Minnesota
Arizona State University

Completed

SMART Optimization of a Parenting Program for Active-duty Families (SMART)

Parenting

United States
enGene, Inc.

Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Superficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

United States
Viriom

Completed

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

Hepatic Impairment | HIV-1-infection

Russian Federation
University of Cape Town
Wellcome Trust; Medecins Sans Frontieres, Netherlands

Completed

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis (RADIANT-TB)

HIV Infections | Tuberculosis

South Africa
University of North Carolina, Chapel Hill
Merck Sharp & Dohme LLC

Completed

Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults

Human Immunodeficiency Virus

United States
University of California, Davis
National Institute of Mental Health (NIMH)

Terminated

Reducing Duration of Untreated Psychosis Through Rapid Identification and Engagement (DUP)

Psychotic Disorders

United States
University of Colorado, Denver

No longer available

Compassionate Use of Ibalizumab for the Treatment of HIV Infection

Human Immunodeficiency Virus (HIV)

United States
Hospices Civils de Lyon

Recruiting

ERAS® Guidelines Validation of CRS With or Without HIPEC

Peritoneal Diseases

United States, Canada, Switzerland
Hospices Civils de Lyon

Completed

Development of a Quality of Life Measurement Scale in Hereditary Haemorrhagic Telangiectasia (HHT) Disease. (ELECT-RO)

Hereditary Hemorrhagic Telangiectasia

France
Riphah International University

Completed

Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.

Coronary Artery Disease

Pakistan
Yooyoung Pharmaceutical Co., Ltd.

Active, not recruiting

Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506

Dyslipidemias

Korea, Republic of
Brigham and Women's Hospital
University of Pennsylvania; Breast Cancer Research Foundation; Ministry of Health... and other collaborators

Completed

Promoting Early Detection of Breast Cancer in Rural Rwanda: Impact of Community Health Worker and Nurse Training (BCED)

Breast Cancer
Abbott Nutrition

Completed

Tolerance of Healthy Infants Fed Infant Formulas

Gastrointestinal Tolerance

United States
Centre Hospitalier Universitaire Dijon

Recruiting

Patient-caregiver Collaboration for Better Cardiovascular Care for Patients With Long-term Mental Disorders: Multicentre Qualitative and Feasibility Studies (COPsyCAT)

Long-term Mental Disorders

France
Aragon Pharmaceuticals, Inc.

Active, not recruiting

Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC)

Prostate Cancer

United States
University of Thessaly

Completed

High Intensity Interval Circuit Training on Resting Metabolic Rate in Overweight Adults

Overweight and Obesity

Greece
Sqy Therapeutics
Biotrial

Recruiting

Phase 1/2a for Safety, PK and PD of SQY51 in Paediatric and Adult Patients Duchenne Muscular Dystrophy (AVANCE1)

Duchenne Muscular Dystrophy

France
St Stephens Aids Trust
Merck Sharp & Dohme LLC

Completed

Renal Integrase Study

HIV

United Kingdom
University Hospitals of Derby and Burton NHS Foundation...
University of Nottingham; National Institute for Health Research, United Kingdom and other collaborators

Completed

The POP-ACLR Study (POP-ACLR)

Anterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Rehabilitation

United Kingdom
University College, London

Completed

SS-INQ Information Needs Questionnaire in Sjögren's Syndrome (SS-INQ)

Sjögren's Syndrome

United Kingdom
Boston Scientific Corporation

Active, not recruiting

A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation (ADVANTAGE AF)

Persistent Atrial Fibrillation

United States, Belgium, Canada, Spain
Scripps Clinic Cancer Center
Threshold Pharmaceuticals

Unknown

TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

United States
Government of Newfoundland and Labrador

Active, not recruiting

JASPER Implementation in NFLD

Autism Spectrum Disorder

Canada
Assistance Publique - Hôpitaux de Paris
URC-CIC Paris Descartes Necker Cochin; MICALIS Institute

Recruiting

Use of Crohn's Disease Exclusion Diet on Top of Standard Therapy Versus Standard Therapy Alone in Unstable Pediatric Crohn's Disease Patients. (ASCENSION)

Crohn's Disease

France
Domain Therapeutics SA

Recruiting

DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours (EPRAD)

Solid Tumor, Adult

France, Belgium
Fred Hutchinson Cancer Center
National Institute on Drug Abuse (NIDA)

Withdrawn

Adaptive Treatment Strategies for Improving Engagement With a Web-Based Smoking Intervention in Socially Anxious Smokers

Tobacco Use Disorder | Social Anxiety Disorder

United States
University of Minnesota
University of California, San Francisco; Posit Science Corporation

Completed

D2D Normative Data for Remote Assessments

Cognition

United States
GT Biopharma, Inc.

Terminated

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Acute Myelogenous Leukemia | Systemic Mastocytosis | Mast Cell Leukemia | High-risk Myelodysplastic Syndromes

United States
Wake Forest University Health Sciences
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Healthy Living Partnership to Prevent Diabetes (HELP PD)

Obesity | Prediabetes

United States
Marmara University

Unknown

Ultrasonographic Evaluation of Changes After Complex Decongestive Therapy

Lymphedema of Upper Arm

Turkey
Drexel University
Esperanza Health Center; The Philadelphia AIDS Consortium

Recruiting

CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos

Anxiety Disorders | Post Traumatic Stress Disorder | Depression, Unipolar

United States
St Stephens Aids Trust

Completed

Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)

HIV

Germany, Spain, France, United Kingdom, Belgium, Italy
Molecular Templates, Inc.

Terminated

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL (MT-3724NHL001)

Leukemia, Lymphocytic, Chronic, B-Cell | Diffuse Large B Cell Lymphoma | Blood Cancer | Hematological Malignancy | Small Lymphocytic Leukemia | Non-Hodgkin's B-cell Lymphoma

United States, Canada, Georgia, Belarus, Spain, Israel, Moldova, Republic of, Poland, Serbia, Ukraine
Duke University
National Institute of Mental Health (NIMH)

Recruiting

Comprehensive Adaptive Multisite Prevention of University Student Suicide (CAMPUS)

Suicide

United States
Instituto de Investigación Hospital Universitario...

Unknown

Antiretroviral Treatment Guided by Proviral Genotype: Pilot Trial of Proof of Concept.

HIV-1-infection

Spain
University of Chicago

Completed

Studies to Determine Whether Oxygen Sensing is Impaired in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Patients

Hypoxia | SARS-CoV-2 Acute Respiratory Disease | Carotid Bodies

United States
VA Office of Research and Development

Completed

Orthostatic Hypotension in Rehabilitation Patients

Hypotension, Orthostatic

United States
Institut Bergonié
Bayer; Merck KGaA, Darmstadt, Germany

Recruiting

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors (REGOMUNE)

Hepatocellular Carcinoma | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Soft-tissue Sarcoma | Urothelial Carcinoma | Thyroid Cancer | Gastro-enteropancreatic Neuroendocrine Tumor | Biliary Tract Cancer | HPV-Related Carcinoma | Solid Tumor, Adult | Mesotheliomas Pleural | GIST | Renal Carcinoma | Colorectal... and other conditions

France
Gilead Sciences

Completed

Safety and Efficacy of Bictegravir + Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

HIV-1 Infection

United States
BioMarin Pharmaceutical

Terminated

A Phase I/II Study of BMN053 in Subjects With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

United Kingdom, Italy, Belgium, Netherlands, France

Search clinical trials for: dolutegravir (Tivicay®) - Phase 1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations